Global Medical Head, Obesity, Injectables Portfolio

AstraZeneca is advancing a tailored approach to Obesity and Weight Management, uniting science, medical and commercial excellence to deliver durable outcomes, reduce cardiometabolic risk and protect organs. Our pipeline is moving with purpose and includes next generation oral and injectable therapies that prioritise tolerability, adaptability and quality of life. Are you ready to be at the forefront of medical innovation? As the Global Medical Head, Obesity, Injectables Portfolio, this role plays a pivotal part in crafting the future of obesity care. This is a chance to use deep expertise to make a real impact on patients’ lives. Join us in our mission to transform the patient journey, from prevention to diagnosis, and beyond.

In this dynamic role, the Global Medical Head, Obesity for our injectables portfolio (SARA and GLP1/GCGR agonists) provides medical leadership across the entire product lifecycle. The role leads a team of talented medical professionals, advises on Research and Development investment decisions, drives pre-launch scientific efforts, and accelerates evidence-based healthcare changes in the real world. Networking and influencing skills are crucial to facilitate cross-functional collaboration and drive innovation. Ready to take on this challenge?

This highly experienced Medical Affairs leader brings validated vision and impact to shape product and disease area strategy, build capability, drive product launches and life cycle management, provide strategic direction for evidence generation, education and publication, and engage extensively externally to further the scientific leadership of AstraZeneca. Reporting directly to the Medical Head of Weight Management and T2D within Medical Affairs Cardiovascular Renal Metabolism (CVRM), this critical strategic leadership position sits on global product and brand teams and leads a global medical team. A strong network with regions and countries will be developed, pairing unique medical expertise with insight from markets, healthcare professionals, patients and health systems to design and implement world-class medical strategies globally. Through this leadership, the role helps build a world-class obesity capability within AstraZeneca, enabling outstanding product launches, practice-defining clinical studies, generation of real-world evidence, transformation of health systems and, ultimately, acceleration of population health.

What You'll Do:

• Provide enterprise leadership by building and leading the global CVRM BPM obesity team, partnering with key stakeholders internally and externally to deliver an integrated medical strategy for the injectables portfolio.
• Set strategic vision and direction by developing, integrating and implementing global strategic medical plans that span early development through launch and life cycle management for SARA and GLP1/GCGR agonists.
• Drive external scientific engagement by defining and driving an ambitious engagement agenda with key external authorities, scientific societies, patient organisations and health system partners to shape healthcare practice in obesity.
• Lead launch excellence, performance management and life-cycle optimisation by defining clear benchmarks, identifying new opportunities in disease state understanding, and ensuring competitive, evidence-based medical plans that anticipate current and future needs.
• Develop evidence generation strategy across clinical development, real-world evidence and health economics to address unmet needs in obesity management, advise guidelines and support access decisions.
• Guide scientific communication, education and publication planning to ensure robust dissemination of data that advises clinical practice and positions AstraZeneca as a trusted scientific partner.
• Act as a key partner across Research and Development and Commercial functions to influence investment decisions, advise brand strategies and ensure alignment between scientific innovation and real-world medical practice.
• Champion cross-functional collaboration across geographies, enabling knowledge sharing, capability building and consistent execution of global medical strategies at regional and local levels.

Essential Skills/Experience

• Sophisticated Scientific Degree (MBBS, PharmD, PhD, or MD) or equivalent education with substantial clinical or research experience relevant to obesity or cardiometabolic disease.
• A minimum of 7 years of experience in the pharmaceutical industry, ideally in Medical Affairs, working at the country and global/regional level
• Experience leading the global CVRM BPM obesity team, partnering with key stakeholders internally and externally
• Experience with the development, integration, and implementation of strategic medical plans at a global level
• Experience driving a bold external engagement agenda, forming strategic alliances and partnerships that can shape healthcare and best practices in the obesity therapy area
• Experience driving innovation and setting key performance indicators (KPIs) to shape disease state understanding, surface new opportunities, and deliver strategic medical plans that are bold for current and future needs

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

At AstraZeneca, medical leaders operate at the intersection of cutting-edge science and real-world practice, acting as scientific ambassadors who understand both the products in our pipeline and their place in evolving standards of care. This environment offers the chance to shape future healthcare through evidence generation, field medical excellence and impactful launches across a rapidly growing portfolio. Collaboration is central: working closely with Research and Development, Commercial teams and external partners worldwide to turn ideas into action that benefits patients. Continuous learning is encouraged as complex science advances quickly, opening new paths for development without borders. Every day brings fresh opportunities to influence clinical practice, contribute to meaningful change for patients living with serious conditions such as obesity, and grow as a leader in an energetic, fast-paced setting.

If this role matches your experience and ambition, apply now to help redefine what is possible in obesity care!

The annual base pay for this position ranges from $283,386 to $425,080 Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.